Sanofi India Q2 Results Review - Margins Remain Resilient Despite NLEM Impact: Nirmal Bang

We remain positive about Sanofi India on the back of pure domestic play, strong balance sheet and reasonable valuation.

<div class="paragraphs"><p>Sanofi India Ltd. (Source: Company's official FB page)</p></div>
Sanofi India Ltd. (Source: Company's official FB page)
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More